PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

2026 ADA Standards of Care in Diabetes Update

Introduces expanded diabetes screening and diagnostic recommendations across diverse populations for pharmacy practice.
ADA Standards of CareAmerican Diabetes AssociationDiabetes MellitusDiagnostic CriteriaScreeningType 1 DiabetesType 2 DiabetesCFRDPTDM Diabetes
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: American Diabetes Association Professional Practice Committee for Diabetes*

Citation: American Diabetes Association Professional Practice Committee for Diabetes* 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes care. 2026;49(Supplement_1):S27-S49. doi:10.2337/dc26-S002

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Suggest a correction Request a topic
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →